Quest Diagnostics Inc (DGX): Cash & Equivalents
$420.00M
As of 2025-12-31
$626.00M
As of 2026-06-30
+10.1%
3-year compound annual growth
-18.4%
5-year compound annual growth
+12.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $420.00M | -23.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $549.00M | -20.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $686.00M | +117.8% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $315.00M | -63.9% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $872.00M | -24.7% | 2023-02-21, Balance as of period end |
| 2020-12-31 | $1.16B | -2.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $1.19B | +783.0% | 2021-02-22, Balance as of period end |
| 2018-12-31 | $135.00M | -1.5% | 2020-02-20, Balance as of period end |
| 2017-12-31 | $137.00M | -61.8% | 2020-02-20, Balance as of period end |
| 2016-12-31 | $359.00M | +169.9% | 2019-02-21, Balance as of period end |
| 2015-12-31 | $133.00M | -30.7% | 2018-02-23, Balance as of period end |
| 2014-12-31 | $192.00M | +2.7% | 2017-02-22, Balance as of period end |
| 2013-12-31 | $187.00M | -36.8% | 2016-02-26, Balance as of period end |
| 2012-12-31 | $296.00M | +79.4% | 2015-02-24, Balance as of period end |
| 2011-12-31 | $165.00M | -63.3% | 2014-02-18, Balance as of period end |
| 2010-12-31 | $449.30M | -15.9% | 2013-02-27, Balance as of period end |
| 2009-12-31 | $534.26M | +110.4% | 2012-02-16, Balance as of period end |
| 2008-12-31 | $253.95M | +51.5% | 2011-02-16, Balance as of period end |
| 2007-12-31 | $167.59M | n/a | 2010-02-17, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $420.00M | -23.5% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $532.30M | -65.0% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $174.60M | +47.3% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $767.22M | +3.7% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $378.20M | -28.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $796.27M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.58M | +51.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $65.43M | -43.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
Compare DGX, LH, FTRE, RDNT side by side · Screen every company in Services-Medical Laboratories ↗